NASDAQ:CPRX

Catalyst Pharmaceuticals Stock Predictions

etoro logo Buy CPRX
*Your capital is at risk
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CPRX Prediction Chart

CPRX Predictions History

Latest community submissions for CPRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 10, 2023 Bullish $19.73 V 1
JS JS Pro
Jan 9, 2023 $19.86 +1.33% $19.02 X 95.58% 0
Jan 9, 2023 $19.20 -2.06% $19.02 V 99.07% 2
Jan 9, 2023 $19.35 -1.29% $19.02 V 98.28% 1
JS JS Pro
Dec 22, 2022 $18.96 -2.77% $19.21 V 98.69% 2
Dec 22, 2022 $18.89 -3.13% $19.21 V 98.32% 1
Dec 22, 2022 $19.05 -2.29% $19.21 V 99.17% 3
JS JS Pro
Nov 25, 2022 $16.92 -0.65% $16.97 V 99.71% 5
AlexVel AlexVel Pro
Nov 25, 2022 $16.95 -0.47% $16.97 V 99.88% 6
Nov 25, 2022 $16.63 -2.32% $16.97 V 98.02% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CPRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CATALYST PHARMACEUTICALS
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE